Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,359 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Protein tag-mediated conjugation of oligonucleotides to recombinant affinity binders for proximity ligation.
Gu GJ, Friedman M, Jost C, Johnsson K, Kamali-Moghaddam M, Plückthun A, Landegren U, Söderberg O. Gu GJ, et al. N Biotechnol. 2013 Jan 25;30(2):144-52. doi: 10.1016/j.nbt.2012.05.005. Epub 2012 Jun 2. N Biotechnol. 2013. PMID: 22664266
Engineered affinity proteins for tumour-targeting applications.
Friedman M, Ståhl S. Friedman M, et al. Biotechnol Appl Biochem. 2009 May;53(Pt 1):1-29. doi: 10.1042/BA20080287. Biotechnol Appl Biochem. 2009. PMID: 19341363 Review.
Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry.
Tolmachev V, Friedman M, Sandström M, Eriksson TL, Rosik D, Hodik M, Ståhl S, Frejd FY, Orlova A. Tolmachev V, et al. J Nucl Med. 2009 Feb;50(2):274-83. doi: 10.2967/jnumed.108.055525. Epub 2009 Jan 21. J Nucl Med. 2009. PMID: 19164241
Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor.
Friedman M, Nordberg E, Höidén-Guthenberg I, Brismar H, Adams GP, Nilsson FY, Carlsson J, Ståhl S. Friedman M, et al. Protein Eng Des Sel. 2007 Apr;20(4):189-99. doi: 10.1093/protein/gzm011. Epub 2007 Apr 23. Protein Eng Des Sel. 2007. PMID: 17452435
Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule.
Nordberg E, Friedman M, Göstring L, Adams GP, Brismar H, Nilsson FY, Ståhl S, Glimelius B, Carlsson J. Nordberg E, et al. Nucl Med Biol. 2007 Aug;34(6):609-18. doi: 10.1016/j.nucmedbio.2007.05.010. Nucl Med Biol. 2007. PMID: 17707800
Generation and evaluation of bispecific affibody molecules for simultaneous targeting of EGFR and HER2.
Ekerljung L, Wållberg H, Sohrabian A, Andersson K, Friedman M, Frejd FY, Ståhl S, Gedda L. Ekerljung L, et al. Bioconjug Chem. 2012 Sep 19;23(9):1802-11. doi: 10.1021/bc3000645. Epub 2012 Aug 29. Bioconjug Chem. 2012. PMID: 22882002
Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule.
Friedman M, Orlova A, Johansson E, Eriksson TL, Höidén-Guthenberg I, Tolmachev V, Nilsson FY, Ståhl S. Friedman M, et al. J Mol Biol. 2008 Mar 7;376(5):1388-402. doi: 10.1016/j.jmb.2007.12.060. Epub 2008 Jan 4. J Mol Biol. 2008. PMID: 18207161
Adenovirus 5 vector genetically re-targeted by an Affibody molecule with specificity for tumor antigen HER2/neu.
Magnusson MK, Henning P, Myhre S, Wikman M, Uil TG, Friedman M, Andersson KM, Hong SS, Hoeben RC, Habib NA, Ståhl S, Boulanger P, Lindholm L. Magnusson MK, et al. Cancer Gene Ther. 2007 May;14(5):468-79. doi: 10.1038/sj.cgt.7701027. Epub 2007 Feb 2. Cancer Gene Ther. 2007. PMID: 17273181
3,359 results
Jump to page
Feedback